December 19, 2021

Volume XI, Number 353

Advertisement
Advertisement

December 17, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
17
Dec
EC Denies Authorization of Titanium Dioxide (E171) as a Feed Additive for All Animal Species, Requires Products Be Withdrawn from the Market in 2022 Bergeson & Campbell, P.C.
16
Dec
New Ruling Throws Healthcare Facility Vaccine Mandates Into State Versus State Barnes & Thornburg LLP
16
Dec
3D Printing Medical Devices at the Point of Care — FDA Invites Feedback Foley & Lardner LLP
16
Dec
OEHHA Modifies Prop 65 Short-Form Warning Proposal Keller and Heckman LLP
16
Dec
EU Proposed Regulation on Deforestation-Free Products: Impact on Food Businesses Greenberg Traurig, LLP
16
Dec
Post-AIA Patents Are Not Shielded from Interferences McDermott Will & Emery
16
Dec
New York City Issues Order, Guidance on COVID-19 Vaccine Requirement for Private Sector Businesses Jackson Lewis P.C.
16
Dec
CMS Issues Guidance on COVID-19 Testing in the Workplace Epstein Becker & Green, P.C.
16
Dec
Rounding Error: Intrinsic Evidence Informs Plain and Ordinary Meaning McDermott Will & Emery
16
Dec
Further Guidance on Overseas Food Facility Registration Published by China Customs Authority Keller and Heckman LLP
16
Dec
Obvious to Try Requires Reasonable Expectation of Success Tethered to Claimed Invention McDermott Will & Emery
16
Dec
Making a List, Checking It Twice: Year-End Guidance on Drug Cost Reporting Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
16
Dec
New Jersey State Health Benefits Program: Multimillion Dollar Cash Cow for Pharma Fraudsters Tycko & Zavareei LLP
15
Dec
Red Light – Green Light: CMS Vaccination Mandate is On Again in 26 States? Foley & Lardner LLP
15
Dec
When Nondisclosure Agreements and Pharmaceutical Trade Secrets Intersect Proskauer Rose LLP
15
Dec
New Bill Aims to Clarify Confusing Food Date Labels Keller and Heckman LLP
14
Dec
Seed to Sale: Keeping Out of the Weeds in Corporate and Financial Transactions Womble Bond Dickinson (US) LLP
14
Dec
FSIS Retail Listeria monocytogenes (Lm) Pilot Project Update Keller and Heckman LLP
14
Dec
Court Cuts Short Challenge to Zicam’s “Clinically Proven to Shorten Colds” Claims Proskauer Rose LLP
14
Dec
CMS Issues Memorandum Stating It Will Not Enforce Its COVID-19 Vaccine Mandate While There are Court-Ordered Injunctions in Place Robinson & Cole LLP

Pages